Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Cell death & disease [Cell Death Dis] NLMUID: 101524092"" wg kryterium: JN


Tytuł :
Sodium butyrate potentiates insulin secretion from rat islets at the expense of compromised expression of β cell identity genes.
Autorzy :
Wang S; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yuan M; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhang L; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhu K; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Sheng C; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhou F; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xu Z; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Liu Q; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Liu Y; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Lu J; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .
Wang X; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .
Zhou L; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .
Pokaż więcej
Źródło :
Cell death & disease [Cell Death Dis] 2022 Jan 19; Vol. 13 (1), pp. 67. Date of Electronic Publication: 2022 Jan 19.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
JMJD2C-mediated long non-coding RNA MALAT1/microRNA-503-5p/SEPT2 axis worsens non-small cell lung cancer.
Autorzy :
Zhang J; Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430022, Wuhan, China.
Wang M; Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430022, Wuhan, China.
Wang J; Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430022, Wuhan, China.
Wang W; Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430022, Wuhan, China. .
Pokaż więcej
Źródło :
Cell death & disease [Cell Death Dis] 2022 Jan 19; Vol. 13 (1), pp. 65. Date of Electronic Publication: 2022 Jan 19.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
STAT6 contributes to renal fibrosis by modulating PPARα-mediated tubular fatty acid oxidation.
Autorzy :
Li J; Medical College of Soochow University, 199 Ren'ai Road, Suzhou, 215123, China.; Department of Nephrology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, China.
Yang Y; School of Public Health, Medical College of Soochow University, 199 Ren'ai Road, Suzhou, 215123, China.
Li Q; School of Public Health, Medical College of Soochow University, 199 Ren'ai Road, Suzhou, 215123, China.
Wei S; School of Public Health, Medical College of Soochow University, 199 Ren'ai Road, Suzhou, 215123, China.
Zhou Y; School of Public Health, Medical College of Soochow University, 199 Ren'ai Road, Suzhou, 215123, China.
Yu W; School of Public Health, Medical College of Soochow University, 199 Ren'ai Road, Suzhou, 215123, China.
Xue L; School of Public Health, Medical College of Soochow University, 199 Ren'ai Road, Suzhou, 215123, China.
Zhou L; Department of Nephrology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, China.
Shen L; Department of Nephrology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, China.
Lu G; Department of Nephrology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, China.
Chen L; School of Public Health, Medical College of Soochow University, 199 Ren'ai Road, Suzhou, 215123, China.
Tao S; Medical College of Soochow University, 199 Ren'ai Road, Suzhou, 215123, China. .; School of Public Health, Medical College of Soochow University, 199 Ren'ai Road, Suzhou, 215123, China. .
Pokaż więcej
Źródło :
Cell death & disease [Cell Death Dis] 2022 Jan 19; Vol. 13 (1), pp. 66. Date of Electronic Publication: 2022 Jan 19.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion.
Autorzy :
Tian W; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Lei N; School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan, China.
Zhou J; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Chen M; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Guo R; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Qin B; Translational Medical Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Li Y; School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan, China. .; Cancer Care Centre, St George Hospital, Kogarah, NSW, Australia. .; St George and Sutherland Clinical School, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW, Australia. .
Chang L; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. .
Pokaż więcej
Źródło :
Cell death & disease [Cell Death Dis] 2022 Jan 18; Vol. 13 (1), pp. 64. Date of Electronic Publication: 2022 Jan 18.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
MCL1 nuclear translocation induces chemoresistance in colorectal carcinoma.
Autorzy :
Fu D; Department of Inflammation and immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Pfannenstiel L; Department of Inflammation and immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Demelash A; Department of Inflammation and immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Phoon YP; Department of Inflammation and immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. .
Mayell C; Cleveland State University, Cleveland, OH, USA.
Cabrera C; Case Western Reserve University, Cleveland, OH, USA.
Liu C; Department of Inflammation and immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Zhao J; Department of Inflammation and immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Dermawan J; Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
Patil D; Digestive Health Research Institute, Case Western Reserve University, Cleveland, OH, USA.
DeVecchio J; Center for Cancer Stem cell Research, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Kalady M; Center for Cancer Stem cell Research, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Souers AJ; Oncology-Discovery, AbbVie Inc, 1 North Waukegan Road, North Chicago, IL, 60064, USA.
Phillips DC; Oncology-Discovery, AbbVie Inc, 1 North Waukegan Road, North Chicago, IL, 60064, USA.
Li X; Department of Inflammation and immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Gastman B; Department of Inflammation and immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. .
Pokaż więcej
Źródło :
Cell death & disease [Cell Death Dis] 2022 Jan 18; Vol. 13 (1), pp. 63. Date of Electronic Publication: 2022 Jan 18.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
The histone methyltransferase DOT1L is a new epigenetic regulator of pulmonary fibrosis.
Autorzy :
Yang D; Pharmacophenomics Laboratory, Human Phenome Institute, Fudan University, 201203, Shanghai, China.
Xu P; Pharmacophenomics Laboratory, Human Phenome Institute, Fudan University, 201203, Shanghai, China.; Department of Pharmacy, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
Su H; Pharmacophenomics Laboratory, Human Phenome Institute, Fudan University, 201203, Shanghai, China.
Zhong W; Pharmacophenomics Laboratory, Human Phenome Institute, Fudan University, 201203, Shanghai, China.
Xu J; Pharmacophenomics Laboratory, Human Phenome Institute, Fudan University, 201203, Shanghai, China.
Su Z; Pharmacophenomics Laboratory, Human Phenome Institute, Fudan University, 201203, Shanghai, China.
Liu X; Pharmacophenomics Laboratory, Human Phenome Institute, Fudan University, 201203, Shanghai, China. .
Pokaż więcej
Źródło :
Cell death & disease [Cell Death Dis] 2022 Jan 17; Vol. 13 (1), pp. 60. Date of Electronic Publication: 2022 Jan 17.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Pathological and therapeutic roles of bioactive peptide trefoil factor 3 in diverse diseases: recent progress and perspective.
Autorzy :
Yang Y; Key Laboratory of Glucolipid Metabolic Diseases of the Ministry of Education, Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Guangdong Pharmaceutical University, Science and Technology Building, 280 Waihuan East Road, Guangzhou Higher Education Mega, Guangzhou, China.
Lin Z; Key Laboratory of Glucolipid Metabolic Diseases of the Ministry of Education, Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Guangdong Pharmaceutical University, Science and Technology Building, 280 Waihuan East Road, Guangzhou Higher Education Mega, Guangzhou, China.
Lin Q; Key Laboratory of Glucolipid Metabolic Diseases of the Ministry of Education, Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Guangdong Pharmaceutical University, Science and Technology Building, 280 Waihuan East Road, Guangzhou Higher Education Mega, Guangzhou, China.
Bei W; Key Laboratory of Glucolipid Metabolic Diseases of the Ministry of Education, Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Guangdong Pharmaceutical University, Science and Technology Building, 280 Waihuan East Road, Guangzhou Higher Education Mega, Guangzhou, China.
Guo J; Key Laboratory of Glucolipid Metabolic Diseases of the Ministry of Education, Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Guangdong Pharmaceutical University, Science and Technology Building, 280 Waihuan East Road, Guangzhou Higher Education Mega, Guangzhou, China. .
Pokaż więcej
Źródło :
Cell death & disease [Cell Death Dis] 2022 Jan 17; Vol. 13 (1), pp. 62. Date of Electronic Publication: 2022 Jan 17.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
POLE2 facilitates the malignant phenotypes of glioblastoma through promoting AURKA-mediated stabilization of FOXM1.
Autorzy :
Zhang P; Department of Neurosurgery of the First Affiliated Hospital of Zhengzhou University, Zhengzhou, No.1 Jianshe East Road, Zhengzhou City, Henan Province, China.
Chen X; Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095 Jiefang Ave, Wuhan City, Hubei Province, China. .
Zhang L; Department of Thyroid and Parathyroid Surgery, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu City, Sichuan Province, China.
Cao D; Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095 Jiefang Ave, Wuhan City, Hubei Province, China.
Chen Y; Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095 Jiefang Ave, Wuhan City, Hubei Province, China.
Guo Z; Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095 Jiefang Ave, Wuhan City, Hubei Province, China.
Chen J; Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095 Jiefang Ave, Wuhan City, Hubei Province, China.
Pokaż więcej
Źródło :
Cell death & disease [Cell Death Dis] 2022 Jan 17; Vol. 13 (1), pp. 61. Date of Electronic Publication: 2022 Jan 17.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Blocking autophagy overcomes resistance to dual histone deacetylase and proteasome inhibition in gynecologic cancer.
Autorzy :
Bi J; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA, 52242, USA.
Zhang Y; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA, 52242, USA.
Malmrose PK; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA, 52242, USA.
Losh HA; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA, 52242, USA.
Newtson AM; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA, 52242, USA.
Devor EJ; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA, 52242, USA.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, 52242, USA.
Thiel KW; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA, 52242, USA.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, 52242, USA.
Leslie KK; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA, 52242, USA. .; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, 52242, USA. .; Division of Molecular Medicine, Departments of Internal Medicine and Obstetrics and Gynecology, the University of New Mexico Comprehensive Cancer Center, University of New Mexico Health Sciences Center, Albuquerque, NM, 87131, USA. .
Pokaż więcej
Źródło :
Cell death & disease [Cell Death Dis] 2022 Jan 17; Vol. 13 (1), pp. 59. Date of Electronic Publication: 2022 Jan 17.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
NEK2 enhances malignancies of glioblastoma via NIK/NF-κB pathway.
Autorzy :
Xiang J; Department of Neurosurgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China.; Center of Brain Science, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China.
Alafate W; Department of Neurosurgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China.; Center of Brain Science, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China.
Wu W; Department of Neurosurgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China.; Center of Brain Science, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China.
Wang Y; Department of Neurosurgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China.; Center of Brain Science, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China.
Li X; Department of Neurosurgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China.; Center of Brain Science, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China.
Xie W; Department of Neurosurgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China.
Bai X; Department of Neurosurgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China.
Li R; Department of Neurosurgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China.
Wang M; Department of Neurosurgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China. .; Center of Brain Science, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China. .
Wang J; Department of Neurosurgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China. .; Center of Brain Science, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China. .
Pokaż więcej
Źródło :
Cell death & disease [Cell Death Dis] 2022 Jan 14; Vol. 13 (1), pp. 58. Date of Electronic Publication: 2022 Jan 14.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
ZC3H15 promotes glioblastoma progression through regulating EGFR stability.
Autorzy :
Hou J; State Key Laboratory of Silkworm Genome Biology, Southwest University, 400716, Chongqing, China.; Cancer Center, Reproductive Medicine Center, Medical Research Institute, Southwest University, 400716, Chongqing, China.
Xu M; State Key Laboratory of Silkworm Genome Biology, Southwest University, 400716, Chongqing, China.; Cancer Center, Reproductive Medicine Center, Medical Research Institute, Southwest University, 400716, Chongqing, China.
Gu H; State Key Laboratory of Silkworm Genome Biology, Southwest University, 400716, Chongqing, China.; Cancer Center, Reproductive Medicine Center, Medical Research Institute, Southwest University, 400716, Chongqing, China.
Pei D; State Key Laboratory of Silkworm Genome Biology, Southwest University, 400716, Chongqing, China.; Cancer Center, Reproductive Medicine Center, Medical Research Institute, Southwest University, 400716, Chongqing, China.
Liu Y; State Key Laboratory of Silkworm Genome Biology, Southwest University, 400716, Chongqing, China.; Cancer Center, Reproductive Medicine Center, Medical Research Institute, Southwest University, 400716, Chongqing, China.
Huang P; State Key Laboratory of Silkworm Genome Biology, Southwest University, 400716, Chongqing, China.; Cancer Center, Reproductive Medicine Center, Medical Research Institute, Southwest University, 400716, Chongqing, China.
Chang H; State Key Laboratory of Silkworm Genome Biology, Southwest University, 400716, Chongqing, China.; Cancer Center, Reproductive Medicine Center, Medical Research Institute, Southwest University, 400716, Chongqing, China.
Cui H; State Key Laboratory of Silkworm Genome Biology, Southwest University, 400716, Chongqing, China. .; Cancer Center, Reproductive Medicine Center, Medical Research Institute, Southwest University, 400716, Chongqing, China. .
Pokaż więcej
Źródło :
Cell death & disease [Cell Death Dis] 2022 Jan 13; Vol. 13 (1), pp. 55. Date of Electronic Publication: 2022 Jan 13.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Exosomal circRELL1 serves as a miR-637 sponge to modulate gastric cancer progression via regulating autophagy activation.
Autorzy :
Sang H; Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
Zhang W; Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
Peng L; Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
Wei S; Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China.; Key Laboratory of Hubei Province for Digestive System Disease, Wuhan, Hubei Province, 430060, China.
Zhu X; Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
Huang K; Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
Yang J; Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
Chen M; Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
Dang Y; Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China. .
Zhang G; Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China. .
Pokaż więcej
Źródło :
Cell death & disease [Cell Death Dis] 2022 Jan 13; Vol. 13 (1), pp. 56. Date of Electronic Publication: 2022 Jan 13.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Cancer-derived exosomal HSPC111 promotes colorectal cancer liver metastasis by reprogramming lipid metabolism in cancer-associated fibroblasts.
Autorzy :
Zhang C; Department of General Surgery, Huashan Hospital, Fudan University, 12 Wulumuqi Road (M), Shanghai, 200040, China.; Institute of Cancer Metastasis, Fudan University, Shanghai, China.
Wang XY; Department of General Surgery, Huashan Hospital, Fudan University, 12 Wulumuqi Road (M), Shanghai, 200040, China.; Institute of Cancer Metastasis, Fudan University, Shanghai, China.
Zhang P; Department of General Surgery, Huashan Hospital, Fudan University, 12 Wulumuqi Road (M), Shanghai, 200040, China.; Institute of Cancer Metastasis, Fudan University, Shanghai, China.
He TC; Department of General Surgery, Huashan Hospital, Fudan University, 12 Wulumuqi Road (M), Shanghai, 200040, China.; Institute of Cancer Metastasis, Fudan University, Shanghai, China.
Han JH; Department of General Surgery, Huashan Hospital, Fudan University, 12 Wulumuqi Road (M), Shanghai, 200040, China.; Institute of Cancer Metastasis, Fudan University, Shanghai, China.
Zhang R; Department of General Surgery, Huashan Hospital, Fudan University, 12 Wulumuqi Road (M), Shanghai, 200040, China.; Institute of Cancer Metastasis, Fudan University, Shanghai, China.
Lin J; Department of General Surgery, Huashan Hospital, Fudan University, 12 Wulumuqi Road (M), Shanghai, 200040, China.; Institute of Cancer Metastasis, Fudan University, Shanghai, China.
Fan J; Department of Pathology, Huashan Hospital, Fudan University, 12 Wulumuqi Road (M), Shanghai, 200040, China.
Lu L; Department of General Surgery, Huashan Hospital, Fudan University, 12 Wulumuqi Road (M), Shanghai, 200040, China.; Institute of Cancer Metastasis, Fudan University, Shanghai, China.
Zhu WW; Department of General Surgery, Huashan Hospital, Fudan University, 12 Wulumuqi Road (M), Shanghai, 200040, China.; Institute of Cancer Metastasis, Fudan University, Shanghai, China.
Jia HL; Department of General Surgery, Huashan Hospital, Fudan University, 12 Wulumuqi Road (M), Shanghai, 200040, China.; Institute of Cancer Metastasis, Fudan University, Shanghai, China.
Zhang JB; Department of Infectious Diseases, Huashan Hospital, Fudan University, 12 Wulumuqi Road (M), Shanghai, 200040, China.
Chen JH; Department of General Surgery, Huashan Hospital, Fudan University, 12 Wulumuqi Road (M), Shanghai, 200040, China. .; Institute of Cancer Metastasis, Fudan University, Shanghai, China. .
Pokaż więcej
Źródło :
Cell death & disease [Cell Death Dis] 2022 Jan 13; Vol. 13 (1), pp. 57. Date of Electronic Publication: 2022 Jan 13.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Linc01133 contributes to gastric cancer growth by enhancing YES1-dependent YAP1 nuclear translocation via sponging miR-145-5p.
Autorzy :
Sun Y; Key Laboratory for Experimental Teratology of the Ministry of Education and Department of Pathology, School of Basic Medical Science, Cheeloo College of Medicine, Shandong University, Jinan, PR China.
Tian Y; Key Laboratory for Experimental Teratology of the Ministry of Education and Department of Pathology, School of Basic Medical Science, Cheeloo College of Medicine, Shandong University, Jinan, PR China.
He J; Department of Pathology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, PR China.
Tian Y; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan, PR China.
Zhang G; Key Laboratory for Experimental Teratology of the Ministry of Education and Department of Pathology, School of Basic Medical Science, Cheeloo College of Medicine, Shandong University, Jinan, PR China.
Zhao R; Key Laboratory for Experimental Teratology of the Ministry of Education and Department of Pathology, School of Basic Medical Science, Cheeloo College of Medicine, Shandong University, Jinan, PR China.
Zhu WJ; Key Laboratory for Experimental Teratology of the Ministry of Education and Department of Pathology, School of Basic Medical Science, Cheeloo College of Medicine, Shandong University, Jinan, PR China. .; Department of Pathology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, PR China. .
Gao P; Key Laboratory for Experimental Teratology of the Ministry of Education and Department of Pathology, School of Basic Medical Science, Cheeloo College of Medicine, Shandong University, Jinan, PR China. .; Department of Pathology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, PR China. .
Pokaż więcej
Źródło :
Cell death & disease [Cell Death Dis] 2022 Jan 11; Vol. 13 (1), pp. 51. Date of Electronic Publication: 2022 Jan 11.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Heterogeneity of tumor microenvironment is associated with clinical prognosis of non-clear cell renal cell carcinoma: a single-cell genomics study.
Autorzy :
Chen WJ; Department of Urology, The Third Affiliated Hospital of Second Military Medical University, 700 North Moyu Road, Shanghai, 201805, China.
Cao H; School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang, 110016, China.; Peking-Tsinghua Center for Life Sciences, Tsinghua University, 100084, Beijing, China.
Cao JW; Department of Urology, Xinhua Hospital, Shanghai Jiaotong University, School of Medicine, 1665 Kongjiang Road, Shanghai, 200092, China.
Zuo L; Department of Urology, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, 29 Xinglong Road, Changzhou, 213000, Jiangsu, China.
Qu FJ; Department of Urology, Xinhua Hospital, Shanghai Jiaotong University, School of Medicine, 1665 Kongjiang Road, Shanghai, 200092, China.
Xu D; Department of Urology, The Third Affiliated Hospital of Second Military Medical University, 700 North Moyu Road, Shanghai, 201805, China.
Zhang H; Department of Orthopedic Oncology, Changzheng Hospital of Second Military Medical University, 415 Fengyang Road, Shanghai, 200003, China.
Gong HY; Department of Orthopedic Oncology, Changzheng Hospital of Second Military Medical University, 415 Fengyang Road, Shanghai, 200003, China.
Chen JX; Department of Urology, The Third Affiliated Hospital of Second Military Medical University, 700 North Moyu Road, Shanghai, 201805, China.
Ye JQ; Department of Urology, The Third Affiliated Hospital of Second Military Medical University, 700 North Moyu Road, Shanghai, 201805, China.
Gan SS; Department of Urology, The Third Affiliated Hospital of Second Military Medical University, 700 North Moyu Road, Shanghai, 201805, China.
Zhou W; Department of Urology, The Third Affiliated Hospital of Second Military Medical University, 700 North Moyu Road, Shanghai, 201805, China.; Department of Urology, Xinhua Hospital, Shanghai Jiaotong University, School of Medicine, 1665 Kongjiang Road, Shanghai, 200092, China.
Zhu DW; Department of Urology, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, 29 Xinglong Road, Changzhou, 213000, Jiangsu, China. .
Pan XW; Department of Urology, The Third Affiliated Hospital of Second Military Medical University, 700 North Moyu Road, Shanghai, 201805, China. .; Department of Urology, Xinhua Hospital, Shanghai Jiaotong University, School of Medicine, 1665 Kongjiang Road, Shanghai, 200092, China. .
Cui XG; Department of Urology, The Third Affiliated Hospital of Second Military Medical University, 700 North Moyu Road, Shanghai, 201805, China. .; Department of Urology, Xinhua Hospital, Shanghai Jiaotong University, School of Medicine, 1665 Kongjiang Road, Shanghai, 200092, China. .
Pokaż więcej
Źródło :
Cell death & disease [Cell Death Dis] 2022 Jan 11; Vol. 13 (1), pp. 50. Date of Electronic Publication: 2022 Jan 11.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Targeting prooxidant MnSOD effect inhibits triple-negative breast cancer (TNBC) progression and M2 macrophage functions under the oncogenic stress.
Autorzy :
Al Haq AT; Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan.; Department of Life Sciences, National Central University, Taoyuan, Taiwan.
Tseng HY; Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan.
Chen LM; Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan.
Wang CC; Department of Life Sciences, National Central University, Taoyuan, Taiwan.
Hsu HL; Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan. .
Pokaż więcej
Źródło :
Cell death & disease [Cell Death Dis] 2022 Jan 11; Vol. 13 (1), pp. 49. Date of Electronic Publication: 2022 Jan 11.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Role of cardiolipins, mitochondria, and autophagy in the differentiation process activated by all-trans retinoic acid in acute promyelocytic leukemia.
Autorzy :
Gianni' M; Laboratory of Molecular Biology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, via Mario Negri 2, 20156, Milano, Italy.
Goracci L; Department of Chemistry, Biology and Biotechnology, University of Perugia, via Elce di Sotto 8, 06123, Perugia, Italy.
Schlaefli A; Institute of Pathology, University of Bern, Murtenstrasse 31, CH-3008, Bern, Switzerland.
Di Veroli A; Department of Chemistry, Biology and Biotechnology, University of Perugia, via Elce di Sotto 8, 06123, Perugia, Italy.
Kurosaki M; Laboratory of Molecular Biology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, via Mario Negri 2, 20156, Milano, Italy.
Guarrera L; Laboratory of Molecular Biology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, via Mario Negri 2, 20156, Milano, Italy.
Bolis M; Laboratory of Molecular Biology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, via Mario Negri 2, 20156, Milano, Italy.; Functional Cancer Genomics Laboratory, Institute of Oncology Research, USI, University of Southern Switzerland, 6500, Bellinzona, Switzerland.; Bioinformatics Core Unit Institute of Oncology Research, Swiss Institute of Bioinformatics, 1000, Lausanne, Switzerland.
Foglia M; Laboratory of Molecular Biology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, via Mario Negri 2, 20156, Milano, Italy.
Lupi M; Department of Oncology, Istituto di Ricerche Farmacologiche 'Mario Negri' IRCCS, via Mario Negri 2, 20156, Milano, Italy.
Tschan MP; Institute of Pathology, University of Bern, Murtenstrasse 31, CH-3008, Bern, Switzerland.
Cruciani G; Department of Chemistry, Biology and Biotechnology, University of Perugia, via Elce di Sotto 8, 06123, Perugia, Italy.
Terao M; Laboratory of Molecular Biology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, via Mario Negri 2, 20156, Milano, Italy.
Garattini E; Laboratory of Molecular Biology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, via Mario Negri 2, 20156, Milano, Italy. .
Pokaż więcej
Źródło :
Cell death & disease [Cell Death Dis] 2022 Jan 10; Vol. 13 (1), pp. 30. Date of Electronic Publication: 2022 Jan 10.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Metformin prevents methylglyoxal-induced apoptosis by suppressing oxidative stress in vitro and in vivo.
Autorzy :
Wang G; Collaborative Innovation Center for Prevention and Treatment of Cardiovascular Disease of Sichuan Province, Drug Discovery Research Center, Southwest Medical University, Luzhou, China.; Laboratory for Cardiovascular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, China.; School of Pharmacy, Chongqing Medical University, Chongqing, China.
Wang Y; Collaborative Innovation Center for Prevention and Treatment of Cardiovascular Disease of Sichuan Province, Drug Discovery Research Center, Southwest Medical University, Luzhou, China.; Laboratory for Cardiovascular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, China.
Yang Q; Collaborative Innovation Center for Prevention and Treatment of Cardiovascular Disease of Sichuan Province, Drug Discovery Research Center, Southwest Medical University, Luzhou, China.; Laboratory for Cardiovascular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, China.
Xu C; Collaborative Innovation Center for Prevention and Treatment of Cardiovascular Disease of Sichuan Province, Drug Discovery Research Center, Southwest Medical University, Luzhou, China.; Laboratory for Cardiovascular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, China.
Zheng Y; Collaborative Innovation Center for Prevention and Treatment of Cardiovascular Disease of Sichuan Province, Drug Discovery Research Center, Southwest Medical University, Luzhou, China.; Laboratory for Cardiovascular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, China.
Wang L; Collaborative Innovation Center for Prevention and Treatment of Cardiovascular Disease of Sichuan Province, Drug Discovery Research Center, Southwest Medical University, Luzhou, China.; Laboratory for Cardiovascular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, China.
Wu J; Collaborative Innovation Center for Prevention and Treatment of Cardiovascular Disease of Sichuan Province, Drug Discovery Research Center, Southwest Medical University, Luzhou, China.; Laboratory for Cardiovascular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, China.
Zeng M; Department of Pharmacy, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China. .
Luo M; Collaborative Innovation Center for Prevention and Treatment of Cardiovascular Disease of Sichuan Province, Drug Discovery Research Center, Southwest Medical University, Luzhou, China. .; Laboratory for Cardiovascular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, China. .; Department of Pharmacy, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China. .
Pokaż więcej
Źródło :
Cell death & disease [Cell Death Dis] 2022 Jan 10; Vol. 13 (1), pp. 29. Date of Electronic Publication: 2022 Jan 10.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Neurokinin-1 receptor promotes non-small cell lung cancer progression through transactivation of EGFR.
Autorzy :
Zhang XW; School of Life Science Lanzhou University, 222 TianShui South Road, Lanzhou, 730000, P. R. China.; Basic Medical Sciences & Research Unit of Peptide Science, Chinese Academy of Medical Sciences, 2019RU066, Lanzhou University, Lanzhou, 730000, P. R. China.; Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Science, Lanzhou University, Lanzhou, 730000, P. R. China.
Li L; School of Life Science Lanzhou University, 222 TianShui South Road, Lanzhou, 730000, P. R. China.; Basic Medical Sciences & Research Unit of Peptide Science, Chinese Academy of Medical Sciences, 2019RU066, Lanzhou University, Lanzhou, 730000, P. R. China.; Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Science, Lanzhou University, Lanzhou, 730000, P. R. China.
Hu WQ; School of Life Science Lanzhou University, 222 TianShui South Road, Lanzhou, 730000, P. R. China.; Basic Medical Sciences & Research Unit of Peptide Science, Chinese Academy of Medical Sciences, 2019RU066, Lanzhou University, Lanzhou, 730000, P. R. China.; Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Science, Lanzhou University, Lanzhou, 730000, P. R. China.
Hu MN; School of Life Science Lanzhou University, 222 TianShui South Road, Lanzhou, 730000, P. R. China.; Basic Medical Sciences & Research Unit of Peptide Science, Chinese Academy of Medical Sciences, 2019RU066, Lanzhou University, Lanzhou, 730000, P. R. China.; Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Science, Lanzhou University, Lanzhou, 730000, P. R. China.
Tao Y; Key Laboratory of Urological Disease of Gansu Province, Lanzhou University Second Hospital, Lanzhou University, Lanzhou, 730000, P. R. China.
Hu H; School of Life Science Lanzhou University, 222 TianShui South Road, Lanzhou, 730000, P. R. China.; Basic Medical Sciences & Research Unit of Peptide Science, Chinese Academy of Medical Sciences, 2019RU066, Lanzhou University, Lanzhou, 730000, P. R. China.
Miao XK; Basic Medical Sciences & Research Unit of Peptide Science, Chinese Academy of Medical Sciences, 2019RU066, Lanzhou University, Lanzhou, 730000, P. R. China.; Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Science, Lanzhou University, Lanzhou, 730000, P. R. China.
Yang WL; Basic Medical Sciences & Research Unit of Peptide Science, Chinese Academy of Medical Sciences, 2019RU066, Lanzhou University, Lanzhou, 730000, P. R. China.; Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Science, Lanzhou University, Lanzhou, 730000, P. R. China.
Zhu Q; School of Life Science Lanzhou University, 222 TianShui South Road, Lanzhou, 730000, P. R. China.
Mou LY; School of Life Science Lanzhou University, 222 TianShui South Road, Lanzhou, 730000, P. R. China. .; Basic Medical Sciences & Research Unit of Peptide Science, Chinese Academy of Medical Sciences, 2019RU066, Lanzhou University, Lanzhou, 730000, P. R. China. .; Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Science, Lanzhou University, Lanzhou, 730000, P. R. China. .
Pokaż więcej
Źródło :
Cell death & disease [Cell Death Dis] 2022 Jan 10; Vol. 13 (1), pp. 41. Date of Electronic Publication: 2022 Jan 10.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
RNF12 is regulated by AKT phosphorylation and promotes TGF-β driven breast cancer metastasis.
Autorzy :
Huang Y; Institute of Basic Medical Sciences and School of Basic Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. .; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands. .
Liu S; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands.
Shan M; Institute of Basic Medical Sciences and School of Basic Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Hagenaars SC; Department of Surgery, Leiden University Medical Centre, Leiden, The Netherlands.
Mesker WE; Department of Surgery, Leiden University Medical Centre, Leiden, The Netherlands.
Cohen D; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Wang L; Institute of Basic Medical Sciences and School of Basic Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zheng Z; Institute of Basic Medical Sciences and School of Basic Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Devilee P; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Tollenaar RAEM; Department of Surgery, Leiden University Medical Centre, Leiden, The Netherlands.
Li Z; Key Laboratory of Cancer and Microbiome, State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Song Y; Key Laboratory of Cancer and Microbiome, State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zhang L; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands. .; Life Sciences Institute, Zhejiang University, Hangzhou, Zhejiang, China. .
Li D; Key Laboratory of Cancer and Microbiome, State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. .
Ten Dijke P; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands.
Pokaż więcej
Źródło :
Cell death & disease [Cell Death Dis] 2022 Jan 10; Vol. 13 (1), pp. 44. Date of Electronic Publication: 2022 Jan 10.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies